Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0066
-0.0074 (-52.86%)
Aug 3, 2026, 11:45 AM EST
YBGJ Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -0.92 | -1.08 | -1.78 | -1.2 | -1.2 | -1.54 |
Depreciation & Amortization | 0.16 | 0.18 | 0.18 | 0.19 | 0.03 | 0.02 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.01 |
Other Operating Activities | -0.1 | -0.11 | 0.01 | - | - | - |
Change in Accounts Receivable | 0.01 | 0.03 | -0.09 | -0.03 | 0.11 | -0.16 |
Change in Inventory | 0.01 | 0.01 | 0.18 | 0.11 | -0.16 | -0.1 |
Change in Accounts Payable | 0.13 | 0.02 | 0.21 | 0.28 | 0.27 | 0.17 |
Change in Other Net Operating Assets | 0.01 | 0.1 | -0.06 | -0.09 | 0.35 | 0.57 |
Operating Cash Flow | -0.66 | -0.84 | -1.34 | -0.74 | -0.6 | -1.02 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | 0.01 | - | - | - | - | -0.56 |
Sale of Property, Plant & Equipment | - | - | 0.12 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | -0.04 | - |
Investing Cash Flow | 0.01 | - | 0.12 | - | -0.04 | -0.56 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.85 | 1.03 | 0.75 | 0.67 | - |
Total Debt Issued | 0.79 | 0.85 | 1.03 | 0.75 | 0.67 | - |
Net Debt Issued (Repaid) | 0.79 | 0.85 | 1.03 | 0.75 | 0.67 | - |
Issuance of Common Stock | - | - | - | - | - | 0.13 |
Other Financing Activities | - | - | 0.37 | - | - | - |
Financing Cash Flow | 0.79 | 0.85 | 1.41 | 0.75 | 0.67 | 0.13 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.13 | -0.01 | -0.19 | -0.02 | -0.04 | 0.1 |
Net Cash Flow | 0 | 0 | 0 | -0.01 | -0.01 | -1.36 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.65 | -0.84 | -1.34 | -0.74 | -0.6 | -1.59 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -5275.88% | -6822.65% | -38551.27% | -122.21% | -576.27% | -127.42% |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.06 | -0.01 | -0.01 |
Levered Free Cash Flow | -0.46 | -0.51 | -2.67 | 0.45 | -0.37 | -0.95 |
Unlevered Free Cash Flow | -0.46 | -0.51 | -2.67 | 0.45 | -0.37 | -0.95 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 0.17 | 0.17 | 0.25 | 0.27 | 0.58 | 0.49 |